Jalbert AC - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Corrigendum to "The use of 'added benefit' to determine the price of new anti-cancer drugs in France, 2004-2017" [Eur J Canc 145 (2021) 11-18].

Rodwin MA, Mancini J, Duran S, Jalbert AC, Viens P, Maraninchi D, Gonçalves A, Marino P. Rodwin MA, et al. Among authors: jalbert ac. Eur J Cancer. 2021 Jul;152:259-261. doi: 10.1016/j.ejca.2021.04.018. Epub 2021 May 11. Eur J Cancer. 2021. PMID: 33994018 No abstract available.

The use of 'added benefit' to determine the price of new anti-cancer drugs in France, 2004-2017.

Rodwin MA, Mancini J, Duran S, Jalbert AC, Viens P, Maraninchi D, Gonçalves A, Marino P. Rodwin MA, et al. Among authors: jalbert ac. Eur J Cancer. 2021 Mar;145:11-18. doi: 10.1016/j.ejca.2020.11.031. Epub 2021 Jan 4. Eur J Cancer. 2021. PMID: 33412466

Gender and racial equity in clinical research for idiopathic pulmonary fibrosis: a systematic review and meta-analysis.

Jalbert AC, Siafa L, Ramanakumar AV, Assayag D. Jalbert AC, et al. Eur Respir J. 2022 Mar 3;59(3):2102969. doi: 10.1183/13993003.02969-2021. Print 2022 Mar. Eur Respir J. 2022. PMID: 35058247 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Search Page

Filters